(1S,2R)-1-PHENYL-2-[(S)-1-HYDROXYPROPYL]-N,N-DI-ISOBUTYLCYCLOPROPANECARBOXAMIDE
Compound with spectra: 1 NMR
![(1S,2R)-1-PHENYL-2-[(S)-1-HYDROXYPROPYL]-N,N-DI-ISOBUTYLCYCLOPROPANECARBOXAMIDE](/api/compound/J1tfuGwjy3Z.png?ph=true&h=300&w=458 "(1S,2R)-1-PHENYL-2-[(S)-1-HYDROXYPROPYL]-N,N-DI-ISOBUTYLCYCLOPROPANECARBOXAMIDE")
| SpectraBase Compound ID | J1tfuGwjy3Z |
|---|---|
| InChI | InChI=1S/C21H33NO2/c1-6-19(23)18-12-21(18,17-10-8-7-9-11-17)20(24)22(13-15(2)3)14-16(4)5/h7-11,15-16,18-19,23H,6,12-14H2,1-5H3/t18-,19-,21+/m0/s1 |
| InChIKey | ZYUAPBVWGVGXOG-IRFCIJBXSA-N |
| Mol Weight | 331.5 g/mol |
| Molecular Formula | C21H33NO2 |
| Exact Mass | 331.251129 g/mol |
| Enantiomer InChIKey | ZYUAPBVWGVGXOG-SBHAEUEKSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S,2R)-1-PHENYL-2-[(S)-1-HYDROXYPROPYL]-N,N-DIPROPYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-PHENYL-2-[(S)-1-HYDROXYPROPYL]-N,N-DIBUTYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-PHENYL-2-[(S)-1-HYDROXYPROPYL]-N,N-CYCLOPENTYLENECYCLOPROPANECARBOXAMIDE
(1S,2R)-1-PHENYL-2-[(S)-1-HYDROXYPROPYL]-N,N-CYCLOHEXYLENECYCLOPROPANECARBOXAMIDE
(1S,2R)-1-(4-METHYLPHENYL)-2-[(S)-1-HYDROXYPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-(4-FLUOROPHENYL)-2-[(S)-1-HYDROXYPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-PHENYL-2-[(S)-1-AMINOPROPYL]-N,N-DIPROPYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,2R)-1-PHENYL-2-[(S)-1-AMINOPROPYL]-N,N-DIBUTYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,2R)-1-PHENYL-2-[(S)-1-AMINOPROPYL]-N,N-CYCLOPENTYLENECYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,2R)-1-PHENYL-2-[(S)-1-AMINOPROPYL]-N,N-CYCLOHEXYLENECYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of (1S,2R)-1-Phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) Derivatives Modified at the Carbamoyl Moiety As a New Class of NMDA Receptor Antagonists | Bioorganic & Medicinal Chemistry | 2002 |